A. Lavolé

3.4k citations

105 papers · 1.7k indexed · h-index 24

Impact in

Oncology top 5%
- Viral-associated cancers and disorders
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Polyomavirus and related diseases
Pulmonary and Respiratory Medicine top 2%
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Tracheal and airway disorders

Papers in ⓘ

Oncology 65
- Viral-associated cancers and disorders 25
- Lung Cancer Research Studies 19
- Cancer Immunotherapy and Biomarkers 17
- Polyomavirus and related diseases 10
Pulmonary and Respiratory Medicine 67
- Lung Cancer Treatments and Mutations 49
- Lung Cancer Diagnosis and Treatment 35
- Medical Imaging and Pathology Studies 10

Co-authors: Marie Wislez (50 shared papers)Jacques Cadranel (44 shared papers)B. Milleron (29 shared papers)V. Gounant (31 shared papers)Anne-Marie Ruppert (23 shared papers)Martine Antoine (23 shared papers)Antoine Parrot (3 shared papers)Nathalie Rabbe (9 shared papers)
Journals: Lung Cancer (12 papers)Journal of Clinical Oncology (9 papers)Annals of Oncology (8 papers)Journal of Thoracic Oncology (5 papers)AIDS (4 papers)
Partner nations: France United States United Kingdom

In The Last Decade

A. Lavolé

99 papers receiving 1.6k citations

Peers

Countries citing papers authored by A. Lavolé

Since Specialization

Citations

This map shows the geographic impact of A. Lavolé's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Lavolé with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Lavolé more than expected).

Fields of papers citing papers by A. Lavolé

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Lavolé. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Lavolé. The network helps show where A. Lavolé may publish in the future.

Co-authors

The 25 scholars most cited alongside A. Lavolé, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with A. Lavolé Line = papers co-authored together A. Lavolé links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 105 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia Medicine ·Vincent Cottin, Thierry Chinet, A. Lavolé, R. Corre, Éric Marchand, Martine Reynaud‐Gaubert, Henri Plauchu, Jean-François Cordier	2007	135
2	Risk of AIDS-Defining Cancers Among HIV-1–Infected Patients in France Between 1992 and 2009: Results From the FHDH-ANRS CO4 Cohort Clinical Infectious Diseases ·Mira Hleyhel, Aurélien Belot, Anne‐Marie Bouvier, Pierre Tattevin, Jérôme Pacanowski, Philippe Genet, Nathalie De Castro, Jean‐Luc Berger, Caroline Dupont, A. Lavolé, Christian Pradier, Dominique Salmon‐Céron, Anne Simon, Valérie Martinez, Dominique Costagliola, Sophie Grabar	2013	73
3	Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO) Journal for ImmunoTherapy of Cancer ·Marie Wislez, Julien Mazières, A. Lavolé, Gérard Zalcman, Olivier Carré, Thomas Egenod, Raffaele Caliandro, Catherine Dubos‐Arvis, G. Jeannin, Olivier Molinier, Marie-Ange Massiani, Alexandra Langlais, Franck Morin, Françoise Le Pimpec‐Barthes, L. Brouchet, Jalal Assouad, B. Milleron, Diane Damotte, Martine Antoine, Virginie Westeel	2022	73
4	Six-month prognosis of patients with lung cancer admitted to the intensive care unit Intensive Care Medicine ·Sébastien Roques, Antoine Parrot, A. Lavolé, Pierre‐Yves Ancel, V. Gounant, Michel Djibré, Muriel Fartoukh	2009	72
5	Pulmonary complications of immune checkpoint inhibitors in patients with nonsmall cell lung cancer European Respiratory Review ·J. Cadranel, Anthony Canellas, Lise Matton, Marie Darrason, Antoine Parrot, Jean‐Marc Naccache, A. Lavolé, Anne-Marie Ruppert, Vincent Fallet	2019	69
6	Lung cancer in HIV infected patients: facts, questions and challenges Thorax ·Jacques Cadranel, D. Garfield, A. Lavolé, Marie Wislez, B. Milleron, C Mayaud	2006	65
7	Blood vessel invasion is a major feature and a factor of poor prognosis in sarcomatoid carcinoma of the lung Lung Cancer ·Thibault Vieira, Martine Antoine, Anne-Marie Ruppert, Vincent Fallet, M. Duruisseaux, Etienne Giroux‐Leprieur, Virginie Poulot, Nathalie Rabbe, Laurene Sclick, Michèle Beau‐Faller, Roger Lacave, A. Lavolé, Jacques Cadranel, Marie Wislez	2014	63
8	Transient HIV-specific T cells increase and inflammation in an HIV-infected patient treated with nivolumab AIDS ·G. Le Garff, Assia Samri, Sidonie Lambert-Niclot, Sophie Even, A. Lavolé, Jacques Cadranel, Jean‐Philippe Spano, Brigitte Autran, Anne‐Geneviève Marcelin, Amélie Guihot	2017	63
9	LBA3_PR An international randomized trial, comparing post-operative conformal radiotherapy (PORT) to no PORT, in patients with completely resected non-small cell lung cancer (NSCLC) and mediastinal N2 involvement: Primary end-point analysis of LungART (IFCT-0503, UK NCRI, SAKK) NCT00410683 Annals of Oncology ·C. Le Péchoux, N. Pourel, Fabrice Barlési, Corinne Faivre‐Finn, D. Lerouge, Gérard Zalcman, D. Antoni, B. Lamezec, Ursula Nestle, P. Boisselier, F. Thillays, A. Paumier, Éric Dansin, Karine Peignaux, J. Madelaine, Éric Pichon, Anne Larrouy, Oliver Riesterer, A. Lavolé, A. Bardet	2020	60
10	Effect of highly active antiretroviral therapy on survival of HIV infected patients with non-small-cell lung cancer Lung Cancer ·A. Lavolé, C. Chouaïd, Laurence Baudrin, Marie Wislez, G Raguin, Gilles Pialoux, Pierre‐Marie Girard, B. Milleron, Jacques Cadranel	2009	49
11	Immunotherapy for cancer in people living with HIV AIDS ·Jean‐Philippe Spano, Marianne Veyri, Aurélien Gobert, Amélie Guihot, Philippe Van de Perre, M. Kerjouan, Solenn Brosseau, Nicolas Cloarec, Henri Montaudié, Carole Hélissey, Thomas Flament, V. Gounant, A. Lavolé, Isabelle Poizot‐Martin, Christine Katlama	2019	49
12	Weekly paclitaxel combined with monthly carboplatin versus single-agent therapy in patients age 70 to 89: IFCT-0501 randomized phase III study in advanced non-small cell lung cancer (NSCLC). Journal of Clinical Oncology ·Élisabeth Quoix, J.P. Oster, V. Westeel, Éric Pichon, Gérard Zalcman, Laurence Baudrin, A. Lavolé, Jérôme Dauba, Marie-Paule Lebitasy, B. Milleron, (unknown)	2010	46
13	Neutrophils Promote Aerogenous Spread of Lung Adenocarcinoma with Bronchioloalveolar Carcinoma Features Clinical Cancer Research ·Marie Wislez, Martine Antoine, Nathalie Rabbe, V. Gounant, Virginie Poulot, A. Lavolé, Jocelyne Fleury‐Feith, Jacques Cadranel	2007	43
14	Factors associated with long‐term survival of patients with advanced non‐small cell lung cancer Respirology ·Etienne Giroux‐Leprieur, A. Lavolé, Anne-Marie Ruppert, V. Gounant, Marie Wislez, Jacques Cadranel, B. Milleron	2011	42
15	Crizotinib Associated with Ground-Glass Opacity Predominant Pattern Interstitial Lung Disease: A Retrospective Observational Cohort Study with a Systematic Literature Review Journal of Thoracic Oncology ·Perrine Créquit, Marie Wislez, Jocelyne Fleury Feith, N. Rozensztajn, L. Jabot, S. Friard, A. Lavolé, V. Gounant, Julie Fillon, Martine Antoine, Jacques Cadranel	2015	41
16	1214O Neoadjuvant durvalumab in resectable non-small cell lung cancer (NSCLC): Preliminary results from a multicenter study (IFCT-1601 IONESCO) Annals of Oncology ·Marie Wislez, Julien Mazières, A. Lavolé, Gérard Zalcman, O. Carré, Thomas Egenod, R. Caliandro, R. Gervais, G. Jeannin, Olivier Molinier, Marie-Ange Massiani, Alexandra Langlais, Franck Morin, Françoise Le Pimpec‐Barthes, L. Brouchet, Jalal Assouad, B. Milleron, Diane Damotte, Martine Antoine, Virginie Westeel	2020	40
17	Lung cancer, a new challenge in the HIV-infected population Lung Cancer ·A. Lavolé, Marie Wislez, Martine Antoine, Charles Mayaud, B. Milleron, Jacquès Cadranel	2005	38
18	Allergic rhinitis to ragweed pollen Journal of Allergy and Clinical Immunology ·C BRUNET, P BEDARD, A. Lavolé, Marie Jobin, Jean‐Louis Hébert	1992	38
19	Sonic Hedgehog Pathway Activation Is Associated With Resistance to Platinum-Based Chemotherapy in Advanced Non–Small-Cell Lung Carcinoma Clinical Lung Cancer ·Etienne Giroux‐Leprieur, Thibault Vieira, Martine Antoine, N. Rozensztajn, Nathalie Rabbe, Anne-Marie Ruppert, A. Lavolé, Jacques Cadranel, Marie Wislez	2015	37
20	Trends in survival after cancer diagnosis among HIV‐infected individuals between 1992 and 2009. Results from the FHDH‐ANRSCO4 cohort International Journal of Cancer ·Mira Hleyhel, Aurélien Belot, Anne‐Marie Bouvier, Pierre Tattevin, Jérôme Pacanowski, Philippe Genet, Nathalie De Castro, Jean‐Luc Berger, Caroline Dupont, A. Lavolé, Christian Pradier, Dominique Salmon‐Céron, Anne Simon, Valérie Martinez, Jean‐Philippe Spano, Dominique Costagliola, Sophie Grabar, (unknown)	2015	34

About A. Lavolé

A. Lavolé is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Microbiology, Pathology and Forensic Medicine and Radiation, having authored 105 papers that have together received 1.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (49 papers), Lung Cancer Diagnosis and Treatment (35 papers), Viral-associated cancers and disorders (25 papers), Lung Cancer Research Studies (19 papers), Cancer Immunotherapy and Biomarkers (17 papers), Lymphoma Diagnosis and Treatment (13 papers), Medical Imaging and Pathology Studies (10 papers) and Polyomavirus and related diseases (10 papers). The work is most often cited by research in Oncology (916 citations), Pulmonary and Respiratory Medicine (897 citations), Genetics (164 citations), Virology (72 citations) and Pathology and Forensic Medicine (187 citations). A. Lavolé has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Marie Wislez, Jacques Cadranel, B. Milleron, V. Gounant, Anne-Marie Ruppert, Martine Antoine, Antoine Parrot, Nathalie Rabbe, Virginie Poulot and Henri Plauchu. Their work appears in journals such as Lung Cancer, Journal of Clinical Oncology, Annals of Oncology, Journal of Thoracic Oncology and AIDS.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact